Chapter 214 [Stage Major Breakthrough]
As time passed, the monkey's blood pressure gradually stabilized, and the abnormal beating of the donor's heart gradually returned to normal. Everyone present couldn't help but breathe a sigh of relief. , but immediately focused on the operation observation.
The intelligent robotic arm skillfully implants the donor heart into the monkey, and then begins to conduct fine suture connections between blood vessels and nerves.
Its operating accuracy is amazing, and the suture of each stitch is just right, just right and impartial. Even the most experienced surgeon is embarrassed when he sees this scene.
After all, the precision control of machines is a height that human hands cannot reach.
The transplant operation was successfully completed except for an unexpected episode. The experimental monkey was transferred to the postoperative observation room. About two and a half hours later, the monkey woke up.
But the anesthesia effect is still there, and it still cannot act independently.
The transplanted heart beats stably and vigorously, and the data show that the monkeys' vital signs are at normal levels.
"We succeeded!"
The members of the entire laboratory were filled with cheers of joy. The success of this heart transplant for monkeys was definitely in the field of intelligent medical care. A historical leap.
Except for Xiao Yu, all the other members of the entire project team did not expect it to be so smooth.
"If this news is announced, surgeons around the world will probably be anxious about unemployment." One of the technical researchers couldn't help laughing, and another said immediately: "Anxiety is certain. , with more than ten years or even decades of experience, I was easily surpassed by AI, and I was uncomfortable and anxious, but the advancement of technology is also an unstoppable trend for individuals. "
Surgeons lost their jobs because of this. It is not that it is a scarce talent, but with the advent of the intelligent medical operating table that can completely replace surgeons in performing surgery, the status and importance of surgeons will definitely decline, and more people will be allowed to go in the future. Do academic research.
After a while, Xiao Yu spoke. He looked around the team members and said calmly: "The project is progressing smoothly, but this is just a phased breakthrough, and it is still far from our true ultimate goal. There is a long way to go, and any challenges that follow will only be more difficult."
Xiao Yu said it with serenely, but in fact the "reference answer" is in his hands. This matter is in his eyes. There is no challenge at all, but the opponents must say that the task is arduous, the challenge is huge, and the future is bright.
Everyone nodded repeatedly when they heard the big boss's words, and they said in their hearts that the big boss was still calm.
Xiao Yu glanced at the experimental monkey and immediately said, "The experimental subjects still need to observe the postoperative recovery, do a good job in data analysis, and further optimize the operating table equipment."
They are present. The members of the project team continued to nod. There are many other experimental plans for the next one. In addition to experimental heart organ transplants, there are also a series of organ transplant experiments including liver, kidneys, etc.
This intelligent medical operating table is to be proficient in various surgical procedures. The ultimate goal is to undertake almost all known surgical tasks and achieve generalization.
The project team's task this year is mainly to use animals to conduct a series of clinical experiments, and will not plan to carry out human clinical experiments next year. This is more troublesome, mainly because of the recruitment of volunteers.
Under normal circumstances, it is highly likely that no one is willing to use their lives to experiment. After all, what if it fails? More than 99% of patients will definitely choose to have experienced surgeons perform their surgery.
But this is not without explanation. The selected target volunteers must be poor people with serious illnesses, have no money to treat, and cannot afford the expensive surgery.
The project team will look for such a goal nationwide. As long as they are willing to accept clinical trials and become volunteers, the project team will bear all the costs for them.
In the situation where you are unable to bear the huge medical expenses, even if the risks are high, you will accept clinical experiments, and at least you can still have a chance. It really doesn't work. At most, you can recruit volunteers through a large reward. The biggest disease in the world is poverty.
There must be brave men under heavy rewards. Although human clinical trials are troublesome, they are not unsolvable.
At the end, Xiao Yu said: "A copy of the videos during the experiment was sent to the company's publicity department, and a copy of the data report was also sorted out, and the sensitive confidential technical parts were removed, and then packaged together to the publicity department."
The person in charge of the project team next to him nodded immediately: "I understand."
This experiment must be a major phased breakthrough, and it will naturally be announced to the public.
…
Two hours later, Xiao Yu posted a news on his personal Weibo:
[I can't wait to reveal some information to everyone. Today, one of our company's project teams has made major technical breakthroughs. This technology is a key pre-technology for achieving a major reduction in the cost of single organ cloning and transplant surgery. Without the support of this technology, the cost of transplant surgery cannot be reduced.
As for what it is, it is a very important and exciting breakthrough in technology. 】
Xiao Yu suddenly posted such a Weibo post, which immediately attracted the attention of people from all walks of life inside and outside the industry, including the majority of netizens who were watching quickly.
The outside world was very surprised. Judging from Xiao Yu's Weibo revelation, it seemed that there had been a big breakthrough in monomer organ cloning, and what was surprised that Lingjing Technology actually made a breakthrough so quickly.
How long has it been? This innovation ability is a bit terrifying.
No mistakes, one poem, one post, one content, one in 6, one book, one bar, one read!
Xiao Yu's post on Weibo attracted speculation from the outside world for a while. Some self-media even opened champagne directly, talking about the fact that single-organ cloning technology may usher in a major breakthrough in stages. Doubling human life span is not a dream .
The traffic of such articles is extremely high. After all, few people can resist the temptation of "double blood bars".
Although Xiao Yu had previously announced that Lingjing Technology had entered the field of modern bioengineering to engage in single-organ cloning technology, and the outside world was quite looking forward to it, many people still think that this big cake is still too far away. Can this generation meet? It's all said two things.
As soon as Xiao Yu posted this Weibo post, it also caused the capital market to become restless. Lingjing Technology's stock price rebounded to 173 yuan in the past week and then fell back to 162 yuan. However, as soon as Xiao Yu posted this Weibo post, The Japanese company's stock price rebounded by +4.77%, closing at the 170.06 yuan mark, with a market value of 14.76 trillion yuan.
Obviously, some funds have begun to grab stocks. Although the price has risen by less than 5 percentage points, the rebound has increased the company's absolute market value by more than 670 billion yuan.
This year's Big A is a year of bearish energy. If the market conditions were good at the beginning of the year, Xiao Yu's Weibo post would definitely make the company's stock price reach more than 10 percentage points.
The capital market and investors are also looking forward to it, but Xiao Yu's information is a bit "like a report". Everyone doesn't know what he kept from selling, nor does it know when it will be announced. In addition, the market is too big and the market is not good. The market just gave a short-term rebound of less than 5 percentage points first, which is already very good.
On the contrary, the village was a little panicked when they learned about this and hurriedly studied countermeasures in advance to manage their expectations.
Because if Lingjing Technology makes a big comeback again, the super giant beast's capital siphon ability will take a sip and other stocks in the market will have to wail.
…
(This chapter ends)